Key facts at a glance
Brittany Maynard, a 29-year-old resident of California, was diagnosed with stage IV glioblastoma in January 2014. She and her husband moved to Oregon to access the state's Death with Dignity Act. She died on November 1, 2014, at home in Hood River, Oregon. The following table summarizes core verified details.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Full name | Brittany Maynard | Reported in news and official statements |
| Age at death | 29 years old | News reports and obituaries |
| Diagnosis | Stage IV glioblastoma (brain cancer) | Published personal statements and interviews |
| Date of death | November 1, 2014 | Oregon state records and news coverage |
| Location of death | Hood River, Oregon, United States | News reports and family statements |
| Legal context | Oregon Death with Dignity Act (physician-assisted dying) | Oregon law and case documentation |
Who was Brittany Maynard
Brittany Maynard was a 29-year-old woman from California who, in 2014, publicly documented her decision to use medical aid in dying under Oregon's Death with Dignity Act. In January 2014, she was diagnosed with stage IV glioblastoma, an aggressive brain cancer. Facing a prognosis with limited treatment options and a rapidly declining quality of life, she and her husband relocated from California to Oregon to legally access physician-assisted dying. Her decision brought widespread attention to end-of-life choice, medical aid in dying, and the intersection of law, ethics, and personal autonomy.
Medical aid in dying and the Death with Dignity Act
Oregon's Death with Dignity Act, enacted in 1997, established a legal framework for physician-assisted dying for terminally ill adults. The law allows eligible residents to request and receive medication to end their lives, administered by a qualified physician. Brittany Maynard qualified under the law because her physicians confirmed a terminal diagnosis with a prognosis of six months or less to live. Her case illustrated how this legal pathway offers options for some individuals when suffering from progressive, incurable illness.
Diagnosis and prognosis
In January 2014, Brittany Maynard received a diagnosis of stage IV glioblastoma, a fast-growing and difficult-to-treat brain tumor. Prognosis for glioblastoma varies, but median survival is often cited in the range of 12 to 18 months with standard treatment; hers was described as stage IV, indicating advanced disease. Her medical team indicated a limited life expectancy, which was central to her decision under Oregon's law. The specifics of her tumor location, treatment course, and clinical details were shared selectively in interviews to protect privacy while informing public understanding.
Decision and public visibility
Brittany Maynard chose to share her story widely through written statements, video messages, and interviews with national media. She framed her choice as one of dignity and control, explaining that she wanted to die on her own terms and avoid prolonged suffering. Her visibility transformed a legal procedure in one state into a national conversation about end-of-life planning, caregiver support, and access to care. She emphasized the importance of open dialogue between patients, families, and healthcare providers when facing terminal illness.
Death and aftermath
Brittany Maynard died at home in Hood River, Oregon, on November 1, 2014. Her death occurred within the legal framework of Oregon's Death with Dignity Act, after she met all statutory requirements. After her death, her story continued to influence policy discussions, activism, and personal planning around medical aid in dying. While her case became highly publicized, it also highlighted persistent gaps in insurance coverage, geographic access, and cultural attitudes toward end-of-life choice.
Impact and legacy
Brittany Maynard's public navigation of a terminal illness and use of physician-assisted dying contributed to increased awareness of medical aid in dying as an option for some terminally ill patients. Organizations on both sides of the debate intensified advocacy efforts, and her story is frequently cited in discussions about expanding access to end-of-life options. Her case is one of several that have shaped public perception and legislative activity in states considering or operating Death with Dignity laws.
Comparison with other U.S. Death with Dignity jurisdictions
Several U.S. states have passed Death with Dignity laws with similar eligibility criteria and procedural safeguards. While each statute is unique, common elements include terminal diagnosis with a limited prognosis, mental capacity requirements, voluntary repeated requests, and physician oversight. The following table summarizes how Oregon compares with other long-standing jurisdictions.
| State | Enacted | Residency requirement | Prognosis requirement | Waiting period | Reporting and oversight |
|---|---|---|---|---|---|
| Oregon | 1997 | Oregon resident | 6-month prognosis | 15-day waiting period (two requests) | Annual state reports |
| Washington | 2008 | Washington resident | 6-month prognosis | 15-day waiting period (two requests) | Annual state reports |
| Vermont | 2013 | Vermont resident | 6-month prognosis | 15-day waiting period (two requests) | Annual reporting |
| California | 2016 | California resident | 15-day waiting period (two requests) | Annual reporting | |
| Colorado | 2016 | Colorado resident | 6-month prognosis | 15-day waiting period (two requests) | Annual reporting |
| Hawaii | 2018 | Hawaii resident | 15-day waiting period (two requests) | Reporting requirements | |
| New Jersey | 2019 | New Jersey resident | 6-month prognosis | 15-day waiting period (two requests) | Reporting requirements |
| Maine | 2019 | Maine resident | 6-month prognosis | 15-day waiting period (two requests) | Reporting requirements |
| New Mexico | 2021 | New Mexico resident | 6-month prognosis | 15-day waiting period (sometimes) | Reporting requirements |
| Nevada | 2021 | Nevada resident | 6-month prognosis | 15-day waiting period (two requests) | Reporting requirements |
FAQs
What was Brittany Maynard's cause of death?
Brittany Maynard died from complications related to her stage IV glioblastoma, the same terminal brain cancer for which she had sought and used medical aid in dying under Oregon law.
Where did Brittany Maynard die?
She died at home in Hood River, Oregon, United States, in the presence of loved ones.
Was Brittany Maynard the first person to use medical aid in dying after the Death with Dignity Act?
No. Oregon's Death with Dignity Act had been in effect since 1997, and Brittany Maynard was one of thousands who have used the law. Her case gained national attention because she publicized her decision while in her twenties and relocated across states to access the law.
Did Brittany Maynard have other treatment options?
She explored conventional treatments, clinical trials, and palliative care. Her decision to pursue aid in dying was shaped by a prognosis of limited benefit from further oncology care and a desire to avoid loss of autonomy and prolonged suffering.
How did her case influence public discourse?
Maynard's visibility helped reframe conversations about medical aid in dying, youth facing terminal illness, and the practical and emotional dimensions of choosing a medically hasted death. It also spurred advocacy, policy research, and continued debate about access and equity.
Are Death with Dignity laws the same in every state?
No. While core elements—terminal diagnosis, prognosis, capacity, and voluntary request—are common, details such as waiting periods, residency requirements, and reporting vary by jurisdiction.